13D/13G Filings - HALOZYME THERAPEUTICS INC. (HALO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-10
10:57 am
Sale
2020-12-31 13G Halozyme Therapeutics, Inc.
HALO
The Vanguard Group 13,149,703
9.730%
-873,756decrease
(-6.23%)
Filing
History
2021-02-10
06:17 am
Sale
2020-12-31 13G Halozyme Therapeutics, Inc.
HALO
Artisan Partners Asset Management Inc. 10,284,136
7.600%
-4,145,901decrease
(-28.73%)
Filing
History
2021-01-26
2:22 pm
Sale
2020-12-31 13G Halozyme Therapeutics, Inc.
HALO
BlackRock Inc.
BLK
18,481,307
13.700%
-202,823decrease
(-1.09%)
Filing
History
2020-12-08
4:56 pm
Purchase
2020-11-30 13G Halozyme Therapeutics, Inc.
HALO
BlackRock Inc.
BLK
18,684,130
13.800%
6,587,333increase
(+54.46%)
Filing
History
Goto Prev, 0, 1